Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
ENLV
ENLV
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ENLV News
Enlivex Launches ENLVon Tokenized Shares on Ondo
Apr 08 2026
Newsfilter
Rain Foundation Launches $5 Million Grant Program for Prediction Markets
Mar 26 2026
Newsfilter
Envilex Therapeutics Reports Strong FY Earnings
Mar 25 2026
seekingalpha
Enlivex Reports Strong 2025 Earnings Driven by Treasury Asset Appreciation
Mar 25 2026
Newsfilter
Enlivex Secures FDA Approval for Phase 2b Trial of Allocetra™
Mar 25 2026
Newsfilter
ENLIVEX REVEALS $21 MILLION IN DEBT FINANCING, UPDATES ON DECENTRALIZED PREDICTION MARKETS AND RAIN TOKEN, AND A $20 MILLION SHARE BUYBACK INITIATIVE
Mar 24 2026
moomoo
Enlivex Therapeutics' RAIN Token Listed on KuCoin, Expected to Enhance Liquidity
Jan 14 2026
Benzinga
Enlivex Adopts First RAIN Prediction Market Token Strategy, Secures $212 Million Funding
Nov 26 2025
Globenewswire
Three Penny Stocks to Keep an Eye On as of November 25, 2025
Nov 25 2025
TipRanks
Dow Rises by 300 Points; Waldencast Stock Takes a Dive
Nov 24 2025
Benzinga
Enlivex Secures $212 Million PIPE and Appoints Former Italian PM Matteo Renzi to Board
Nov 24 2025
Newsfilter
D. Boral Capital Lowers Enlivex Therapeutics Rating to Hold
Nov 24 2025
Benzinga
Nasdaq Rises by 350 Points; Enlivex Therapeutics Stock Jumps Significantly
Nov 24 2025
Benzinga
Enlivex Launches RAIN Prediction Markets Token Strategy with $212 Million PIPE Financing
Nov 24 2025
Newsfilter
EXCLUSIVE: Enlivex Secures More Than $200 Million to Initiate First Public Company Prediction Markets Venture
Nov 24 2025
Benzinga
Enlivex Reports Six-Month Efficacy Data for Allocetra™ in Knee Osteoarthritis
Nov 24 2025
Newsfilter
Show More News
